![Page 1: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/1.jpg)
Shawn T. Leonard MT(ASCP)Blood Centers of the Pacific
Antibody Exclusion“Crossing-Out”
Interpreting Panel Results
![Page 2: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/2.jpg)
•Performing selected tests
•Determining the strength & pattern of agglutination
•Interpreting results
•Selecting suitable blood for the patient
Antibody Identification Antibody Identification Involves YOU as the
Expert!
![Page 3: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/3.jpg)
•Define Antibody Exclusion
•List advantages of crossing out in Ab Identification
•Describe limitations of the cross-out process
•Identify helpful patient and reagent information
•Discuss AABB Standards on assigning Ab specificity
•Recognize homozygous vs. heterozygous expression
•Apply recommended rules for crossing out
Objectives
![Page 4: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/4.jpg)
Systematic process by which panel results are interpreted to eliminate antibody specificities on the basis of non-reactivity of patient plasma with red cell samples that express the antigen.
-AABB Technical Manual 16th edition
““Antibody Exclusion” – Antibody Exclusion” – Immunohematology Immunohematology
definitiondefinition
![Page 5: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/5.jpg)
Commonly known as…
““Antibody Exclusion” – Antibody Exclusion” – Immunohematology definitionImmunohematology definition
Crossing-OutCrossing-Out
![Page 6: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/6.jpg)
1.1. Allows accurate ID of antibodies Allows accurate ID of antibodies 2.2. Eliminates additional antibody specificitiesEliminates additional antibody specificities3.3. Provides higher predictive valueProvides higher predictive value4.4. Supports initial hypothesis Supports initial hypothesis 5.5. Determines additional testingDetermines additional testing6.6. Decreases delay in patient careDecreases delay in patient care
Advantages of Crossing-Out
![Page 7: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/7.jpg)
• A first approach
• May not lead directly to an answer
• A provisional step
• Converging evidence ???
Crossing Out
![Page 8: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/8.jpg)
• Patient’s phenotype
• Ethnicity of the patient
• Ethnicity of panel cell donor
• Age of the panel cell
Helpful Information
![Page 9: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/9.jpg)
Cross-Out protocol varies by institution
Recommended rules for Crossing-Out
![Page 10: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/10.jpg)
To increase the probability of correct identification a p-value of <0.05 is observed
which gives a 95% confidence interval.
What about Ruling-In?
![Page 11: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/11.jpg)
Standards for Immunohematology Reference Laboratories-6th Edition
“Assign specificity after demonstrating reactivity with at least two antigen-positive reagent red cell samples and non-reactivity with at least two antigen-negative reagent red cell samples.”
AABB IRL Standards
![Page 12: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/12.jpg)
Recommended rules for Crossing-Out
![Page 13: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/13.jpg)
It is best to rule out an antibody specificity on a cell with a double-dose expression
• Homozygous alleles - Jka/Jka (Double-Dose)
express Jk(a+b-)
• Heterozygous alleles - Jka/Jkb (Single-Dose)
express Jk(a+b+)
Rule #1
![Page 14: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/14.jpg)
It is best to rule out an antibody specificity on a cell with a double-dose expression
Exceptions…
• K1 and P1
• C or E with Anti-D
Rule #1
![Page 15: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/15.jpg)
It is better to rule out specificities with two unique cells rather than one
By chance, one may not react as well as expected due to:
•Variant antigen structure•Lack of antigen recognition by antibody•Weakened antigen expression•Antigen degradation•Tech error
Rule #2
![Page 16: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/16.jpg)
“ Reverse of Rule-out ”- for the antibody that shows extreme variability or reacts in more than one phase of testing
•Anti-P1
•Anti-Lea
•Anti-Leb
Rule #3
![Page 17: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/17.jpg)
Antibody Exclusion alone does not define which antibodies are or are not present
Additional Techniques :
• Selected Cells• Chemical Treatment
Proteolytic Enzymes - Papain, Ficin, Bromelin
Sulfhydryl Reagents - DTT & AET• NeutralizationP1 & Lewis
Rule #4
![Page 18: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/18.jpg)
If antibodies to common blood group antigens cannot be ruled out, it may be necessary to consult a Blood Bank Reference Laboratory or provide antigen negative units.
When All Else FailsWhen All Else Fails
![Page 19: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/19.jpg)
On the following example panels, try crossing out each blood group antigen with at least one homozygous representation.
Example PanelsExample Panels
![Page 20: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/20.jpg)
CC
EE
LL
LL
RHRH KellKell DuffyDuffy KiddKidd LewisLewis PP MNSMNSCC
EE
LL
LL
GG
EE
LL
IATIAT
DD CC EE cc ee KK kk FyFyaa FyFybb JkJkaa JkJkbb LeLeaa LeLebb PP11 MM NN SS ss
1 + + 0 0 + 0 + + + + 0 0 + 0 + + 0 + 1 4+4+
2 + + 0 0 + + + 0 + 0 + + 0 + + + + + 2 4+4+
3 + 0 + + 0 0 + 0 + + 0 0 + 0 + + + + 3 00
4 + 0 0 + + 0 + 0 0 + 0 0 0 + 0 + 0 + 4 00
5 0 + 0 + + 0 + 0 + + 0 + 0 +s 0 + 0 + 5 4+4+
6 0 0 + + + 0 + + 0 0 + 0 + + + + + + 6 00
7 0 0 0 + + + + 0 + + + 0 + + + + + + 7 00
8 0 0 0 + + 0 + 0 + + + 0 + + + 0 + 0 8 00
9 0 0 0 + + 0 + + 0 + 0 + 0 + + + 0 + 9 00
10 0 0 0 + + 0 + + + 0 + 0 + + 0 + 0 + 10 00
11 + + 0 0 + 0 + 0 + + 0 0 0 + + + + 0 11 4+4+
AC AC 00
(Panel A)Example #1
![Page 21: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/21.jpg)
CC
EE
LL
LL
RHRH KellKell DuffyDuffy KiddKidd LewisLewis PP MNSMNSCC
EE
LL
LL
GG
EE
LL
IATIAT
DD CC EE cc ee KK kk FyFyaa FyFybb JkJkaa JkJkbb LeLeaa LeLebb PP11 MM NN SS ss
1 + + 0 0 + 0 + + + + 0 0 + 0 + + 0 + 1 00
2 + + 0 0 + + + 0 + 0 + + 0 + + + + + 2 3+3+
3 + 0 + + 0 0 + 0 + + 0 0 + 0 + + + + 3 3+3+
4 + 0 0 + + 0 + 0 0 + 0 0 0 + 0 + 0 + 4 00
5 0 + 0 + + 0 + 0 + + 0 + 0 +S 0 + 0 + 5 00
6 0 0 + + + 0 + + 0 0 + 0 + + + + + + 6 3+3+
7 0 0 0 + + + + 0 + + + 0 + + + + + + 7 3+3+
8 0 0 0 + + 0 + 0 + + + 0 + + + 0 + 0 8 3+3+
9 0 0 0 + + 0 + + 0 + 0 + 0 + + + 0 + 9 00
10 0 0 0 + + 0 + + + 0 + 0 + + 0 + 0 + 10 00
11 + + 0 0 + 0 + 0 + + 0 0 0 + + + + 0 11 3+3+
AC AC 00
(Panel A)Example #2
![Page 22: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/22.jpg)
CC
EE
LL
LL
RHRH KellKell DuffyDuffy KiddKidd LewisLewis PP MNSMNSCC
EE
LL
LL
GG
EE
LL
IATIAT
DD CC EE cc ee KK kk FyFyaa FyFybb JkJkaa JkJkbb LeLeaa LeLebb PP11 MM NN SS ss
12 0 0 0 + + 0 + 0 + + 0 0 + + + + + 0 1 3+3+
13 0 0 0 + + + + + + 0 + 0 + +S + 0 0 + 2 00
14 0 0 0 + + 0 + + 0 0 + 0 + + + + 0 + 3 00
15 + 0 + + 0 0 + + 0 + + + 0 +S + + 0 + 4 2+2+
16 + 0 + + 0 0 + + + 0 + 0 + 0 + + + + 5 3+3+
17 + 0 + + 0 0 + 0 + + 0 + 0 + + 0 + + 6 3+3+
18 + + 0 0 + 0 + 0 + + 0 + 0 0 0 + 0 + 7 00
19 + + 0 0 + 0 + + 0 0 + 0 + + + 0 + 0 8 3+3+
20 + + + 0 + 0 + + 0 + + 0 + +S + + 0 + 9 2+2+
21 0 + 0 + + 0 + 0 + + + 0 + + + 0 0 + 10 00
22 + + 0 0 + + 0 0 + + 0 0 + + + + + + 11 3+3+
AC AC 00
(Panel B)Example #2
![Page 23: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/23.jpg)
CC
EE
LL
LL
RHRH KellKell DuffyDuffy KiddKidd LewisLewis PP MNSMNSCC
EE
LL
LL
GG
EE
LL
IATIAT
DD CC EE cc ee KK kk FyFyaa FyFybb JkJkaa JkJkbb LeLeaa LeLebb PP11 MM NN SS ss
1 + + 0 0 + 0 + + + + 0 0 + 0 + + 0 + 1 4+4+
2 + + 0 0 + + + 0 + 0 + + 0 + + + + + 2 4+4+
3 + 0 + + 0 0 + 0 + + 0 0 + 0 + + + + 3 4+4+
4 + 0 0 + + 0 + 0 0 + 0 0 0 + 0 + 0 + 4 4+4+
5 0 + 0 + + 0 + 0 + + 0 + 0 +s 0 + 0 + 5 00
6 0 0 + + + 0 + + 0 0 + 0 + + + + + + 6 00
7 0 0 0 + + + + 0 + + + 0 + + + + + + 7 00
8 0 0 0 + + 0 + 0 + + + 0 + + + 0 + 0 8 00
9 0 0 0 + + 0 + + 0 + 0 + 0 + + + 0 + 9 00
10 0 0 0 + + 0 + + + 0 + 0 + + 0 + 0 + 10 00
11 + + 0 0 + 0 + 0 + + 0 0 0 + + + + 0 11 4+4+
AC AC 00
(Panel A)Example #3
![Page 24: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/24.jpg)
CC
EE
LL
LL
RHRH KellKell DuffyDuffy KiddKidd LewisLewis PP MNSMNSCC
EE
LL
LL
LISSLISS
3737oo
LISSLISS
IATIATDD CC EE cc ee KK kk FyFyaa FyFybb JkJkaa JkJkbb LeLeaa LeLebb PP11 MM NN SS ss
1 + + + 0 + 0 + + 0 + 0 0 + + + + + 0 1 00 00
2 + + 0 0 + 0 + 0 + 0 + 0 + + + 0 0 + 2 1+1+ 1+1+
3 + 0 + + 0 0 + 0 + 0 + 0 + 0 0 + + 0 3 00 00
4 + 0 0 + + 0 + 0 0 + + 0 + + + + + 0 4 00 00
5 0 + 0 + + 0 + + 0 0 + 0 + + + 0 + 0 5 1+1+ 1+1+
6 0 0 + + + 0 + 0 + + + 0 + + + + 0 + 6 00 00
7 0 0 0 + + + + 0 + 0 + 0 + + + 0 + + 7 1+1+ 1+1+
8 0 0 0 + + 0 + + 0 + 0 + 0 0 0 + + + 8 00 00
9 0 0 0 + + 0 + + 0 + + + 0 0 + 0 0 + 9 1+1+ 1+1+
10 + + 0 0 + + + 0 + + 0 0 + + + + + 0 10 00 00
11 0 0 0 + + 0 + 0 + + 0 0 + 0 0 + + 0 11 00 00
AC AC 00 00
Example #4
![Page 25: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/25.jpg)
CC
EE
LL
LL
RHRH KellKell DuffyDuffy KiddKidd LewisLewis PP MNSMNSCC
EE
LL
LL
LISSLISS
IATIATDD CC EE cc ee KK kk FyFyaa FyFybb JkJkaa JkJkbb LeLeaa LeLebb PP11 MM NN SS ss
1 + + + 0 + 0 + + + + 0 + 0 + + + 0 + 1 w+w+
2 + + 0 0 + + + 0 + + + 0 0 0 0 + 0 + 2 00
3 + 0 + + 0 0 + 0 + + 0 0 0 + 0 + + + 3 00
4 + 0 0 + + 0 + + 0 + + 0 + + 0 + 0 0 4 1+1+
5 0 + 0 + + 0 + + + 0 + 0 + + + + 0 + 5 w+w+
6 0 0 + + + 0 + + 0 0 + 0 + + + + 0 + 6 00
7 0 0 0 + + + + 0 + 0 + + 0 0 + 0 + 0 7 00
8 0 0 0 + + 0 + + 0 0 + 0 0 + + 0 + 0 8 w+w+
9 0 0 0 + + 0 + 0 0 + + 0 + +S 0 + 0 + 9 2+2+
10 + + 0 0 + + 0 + + 0 + 0 + + + 0 + + 10 00
11 + + 0 0 + 0 + + 0 + + + 0 0 + + 0 + 11 00
AC AC 00
Example #5
![Page 26: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/26.jpg)
CC
EE
LL
LL
RHRH KellKell DuffyDuffy KiddKidd LewisLewis PP MNSMNSCC
EE
LL
LL
RTRT
15’15’
PP11
Neut.Neut.
RTRT
15’15’DD CC EE cc ee KK kk FyFyaa FyFybb JkJkaa JkJkbb LeLeaa LeLebb PP11 MM NN SS ss
1 + + + 0 + 0 + + + + 0 + 0 + + + 0 + 1 1+1+ 00
2 + + 0 0 + + + 0 + + + 0 0 0 0 + 0 + 2 00 00
3 + 0 + + 0 0 + 0 + + 0 0 0 + 0 + + + 3 1+1+ 00
4 + 0 0 + + 0 + + 0 + + 0 + + 0 + 0 0 4 1+1+ 00
5 0 + 0 + + 0 + + + 0 + 0 + + + + 0 + 5 1+1+ 00
6 0 0 + + + 0 + + 0 0 + 0 + + + + 0 + 6 1+1+ 00
7 0 0 0 + + + + 0 + 0 + + 0 0 + 0 + 0 7 00 00
8 0 0 0 + + 0 + + 0 0 + 0 0 + + 0 + 0 8 1+1+ 00
9 0 0 0 + + 0 + 0 0 + + 0 + +S 0 + 0 + 9 2+2+ 00
10 + + 0 0 + + 0 + + 0 + 0 + + + 0 + + 10 1+1+ 00
11 + + 0 0 + 0 + + 0 + + + 0 0 + + 0 + 11 00 00
AC AC
(RT & P1 Neut.)Example #5
![Page 27: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/27.jpg)
CC
EE
LL
LL
RHRH KellKell DuffyDuffy KiddKidd LewisLewis PP MNSMNSCC
EE
LL
LL
LISSLISS
3737oo
LISSLISS
IATIATDD CC EE cc ee KK kk FyFyaa FyFybb JkJkaa JkJkbb LeLeaa LeLebb PP11 MM NN SS ss
1 + + + 0 + 0 + 0 + 0 + 0 + + + 0 + + 1 1+1+ 2+2+
2 + + 0 0 + 0 + 0 + + 0 0 + 0 0 + 0 + 2 00 2+2+
3 + 0 + + 0 0 + 0 + 0 + 0 + + 0 + 0 + 3 1+1+ 2+2+
4 + 0 0 + + 0 + + 0 + + 0 + + + + 0 + 4 00 00
5 0 + 0 + + 0 + + + + 0 0 + + + 0 + + 5 00 2+2+
6 0 0 + + + 0 + + 0 0 + 0 + + + + 0 + 6 1+1+ 2+2+
7 0 0 0 + + + + 0 + + + + 0 + + + + + 7 00 00
8 0 0 0 + + 0 + + 0 + + + 0 0 0 + + + 8 00 00
9 0 0 0 + + 0 + + 0 + 0 + 0 + + + + + 9 00 2+2+
10 + + 0 0 + + + + + + 0 0 + + 0 + 0 + 10 00 2+2+
11 + + 0 0 + 0 + + 0 0 + 0 + 0 + 0 + 0 11 00 00
AC AC 00 00
Example #6
![Page 28: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/28.jpg)
CC
EE
LL
LL
RHRH KellKell DuffyDuffy KiddKidd LewisLewis PP MNSMNSCC
EE
LL
LL
LISSLISS
IATIATDD CC EE cc ee KK kk FyFyaa FyFybb JkJkaa JkJkbb LeLeaa LeLebb PP11 MM NN SS ss
1 + + 0 0 + + + + + + 0 + 0 + 0 + + 0 1 3+3+
2 + + 0 0 + 0 + 0 + 0 + 0 + + 0 + + + 2 2+2+
3 + 0 + + 0 0 + 0 0 0 + 0 + 0 + 0 + + 3 2+2+
4 + 0 0 + + 0 + 0 0 + 0 0 + + + + 0 0 4 00
5 0 + 0 + + + + + 0 + 0 0 + 0 0 + + 0 5 2+2+
6 0 0 + + + 0 + 0 + + + 0 + + 0 + + + 6 4+4+
7 0 0 0 + + + + + 0 + + + 0 + + + 0 + 7 2+2+
8 0 0 0 + + 0 + + 0 0 + 0 + + + 0 + + 8 00
9 0 0 0 + + 0 + 0 + + + 0 + + + 0 + 0 9 2+2+
10 + + + + 0 0 + 0 + + + 0 0 + 0 + 0 + 10 4+4+
11 + + 0 0 + 0 + 0 0 + 0 + 0 + 0 + 0 + 11 00
AC AC 00
Example #7
![Page 29: Shawn T. Leonard MT(ASCP) Blood Centers of the Pacific Antibody Exclusion “Crossing-Out” Interpreting Panel Results](https://reader035.vdocuments.net/reader035/viewer/2022062718/56649ebe5503460f94bc7dcc/html5/thumbnails/29.jpg)
CC
EE
LL
LL
RHRH KellKell DuffyDuffy KiddKidd LewisLewis PP MNSMNSLL
II
SS
SS
IATIAT
EE
NN
ZZ
IATIAT
DD
TT
TTIATIAT
DD CC EE cc ee KK kk FyFyaa FyFybb JkJkaa JkJkbb LeLeaa LeLebb PP11 MM NN SS ss
1 + + 0 0 + + + + + + 0 + 0 + 0 + + 0 3+3+ 2+2+ 2+2+
2 + + 0 0 + 0 + 0 + 0 + 0 + + 0 + + + 2+2+ 00 2+2+
3 + 0 + + 0 0 + 0 0 0 + 0 + 0 + 0 + + 2+2+ 3+3+ 2+2+
4 + 0 0 + + 0 + 0 0 + 0 0 + + + + 0 0 00 00 00
5 0 + 0 + + + + + 0 + 0 0 + 0 0 + + 0 2+2+ 2+2+ 00
6 0 0 + + + 0 + 0 + + + 0 + + 0 + + + 4+4+ 3+3+ 4+4+
7 0 0 0 + + + + + 0 + + + 0 + + + 0 + 2+2+ 2+2+ 00
8 0 0 0 + + 0 + + 0 0 + 0 + + + 0 + + 00 00 00
9 0 0 0 + + 0 + 0 + + + 0 + + + 0 + 0 2+2+ 00 2+2+
10 + + + + 0 0 + 0 + + + 0 0 + 0 + 0 + 4+4+ 3+3+ 4+4+
11 + + 0 0 + 0 + 0 0 + 0 + 0 + 0 + 0 + 00 00 00
AC 00
(Chemicals)Example #7